名稱 | AI-Edigene® IDH2 p.R140Q Reference Standard P |
型號(hào) | CBP10513 |
報(bào)價(jià) | ![]() |
特點(diǎn) | AI-Edigene® IDH2 p.R140Q Reference Standard Plus |
產(chǎn)品搜索
相關(guān)文章
- GLP1R藥靶篩選模型應(yīng)用展示
- 非小細(xì)胞肺癌免疫治療 先放療更有效
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 購(gòu)買細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn):ADORA2B(腺苷A2B受體)
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 探討腫瘤細(xì)胞的“冷與熱”之分
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- NCRI:新型檢測(cè)技術(shù)或能提前8年診斷出食管癌
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10513AI-Edigene® IDH2 p.R140Q Reference Standard P

- 詳細(xì)內(nèi)容
CBP10513 | |
Format | Genomic DNA |
Description | IDH2 R140Q lies within the substrate binding region of the Idh2 protein (UniProt.org). R140Q confers a gain of function to Idh2, enabling conversion of alpha-ketoglutarate to the onco-metabolite 2HG (R(-)-2-hydroxyglutarate), results in increased 2HG levels in patient samples, and is transforming in cell culture (PMID: 20171147, PMID: 23558173). |
Technical Data | |
DNA Change | c.419G>A |
AA Change | p.R140Q |
Mutation type | Substitution - Missense |
Zygosity | Homozygous |
Allelic Frequency | 100% |
Transcript | NM_002168.4 |
Cosmic ID | COSM41590 |
Chr position(GRCh37) | chr15:90631934 |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | 4°C |
Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">